
AR-A014418
CAS No. 487021-52-3
AR-A014418( AR-AO 14418 | AR 0133418 | AR 014418 | GSK 3β inhibitor )
Catalog No. M14634 CAS No. 487021-52-3
A potent, specific ATP-competitive inhibitor of GSK-3β with Ki/IC50 of 38/104 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 41 | In Stock |
![]() ![]() |
10MG | 48 | In Stock |
![]() ![]() |
25MG | 82 | In Stock |
![]() ![]() |
50MG | 149 | In Stock |
![]() ![]() |
100MG | 259 | In Stock |
![]() ![]() |
200MG | 336 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAR-A014418
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, specific ATP-competitive inhibitor of GSK-3β with Ki/IC50 of 38/104 nM.
-
DescriptionA potent, specific ATP-competitive inhibitor of GSK-3β with Ki/IC50 of 38/104 nM; shows no significantly inhibition on CDK2, CDK5 (IC50>100 uM) or 26 other kinases; inhibits tau phosphorylation at a GSK3-specific site (Ser-396) in cells and protects N2A neuroblastoma cells against cell death mediated by inhibition of PI3K/Akt pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsAR-AO 14418 | AR 0133418 | AR 014418 | GSK 3β inhibitor
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3β
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number487021-52-3
-
Formula Weight308.3131
-
Molecular FormulaC12H12N4O4S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCOc1ccc(cc1)CNC(=O)Nc2ncc(s2)[N+](=O)[O-]
-
Chemical NameUrea, N-[(4-methoxyphenyl)methyl]-N'-(5-nitro-2-thiazolyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bhat R, et al. J Biol Chem. 2003 Nov 14;278(46):45937-45.
2. Martins DF, et al. J Pain. 2011 Mar;12(3):315-22.
3. Mazzardo-Martins L, et al. Neuroscience. 2012 Dec 13;226:411-20.
molnova catalog



related products
-
A 1070722
A 1070722 is a potent and selective GSK-3 inhibitor, shows high affinity GSK-3α(Ki = 0.6 nM) and GSK-3β(Ki = 0.6 nM).
-
PF-04802367
A potent, highly selective GSK-3 inhibitor with IC50 of 2.1 nM for human GSK-3β in enzyme assays.
-
VP3.15 dihydrobromid...
VP3.15 dihydrobromide is a potent orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM 0.88 μMrespectively.)